# A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

> **NCT01570582** · PHASE2 · UNKNOWN · sponsor: **Korean Gynecologic Oncology Group** · enrollment: 314 (estimated)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Cancer

## Interventions

- **DRUG:** carboplatin and paclitaxel

## Key facts

- **NCT ID:** NCT01570582
- **Lead sponsor:** Korean Gynecologic Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2012-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570582, "A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01570582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*